• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Serum Levels of MMP-8 and MMP-9 as Markers in Chronic Subdural Hematoma.血清中基质金属蛋白酶-8和基质金属蛋白酶-9水平作为慢性硬膜下血肿的标志物
J Clin Med. 2022 Feb 9;11(4):902. doi: 10.3390/jcm11040902.
2
Immunoexpression of MMP-8 and MMP-9 in chronic subdural hematoma.基质金属蛋白酶-8和基质金属蛋白酶-9在慢性硬膜下血肿中的免疫表达
Front Neurol. 2022 Aug 17;13:988854. doi: 10.3389/fneur.2022.988854. eCollection 2022.
3
Role of Matrix Metalloproteinase-2, Matrix Metalloproteinase-9, and Vascular Endothelial Growth Factor in the Development of Chronic Subdural Hematoma.基质金属蛋白酶-2、基质金属蛋白酶-9和血管内皮生长因子在慢性硬膜下血肿形成中的作用
J Neurotrauma. 2016 Jan 1;33(1):65-70. doi: 10.1089/neu.2014.3724. Epub 2015 Aug 6.
4
A novel rat model of chronic subdural hematoma: Induction of inflammation and angiogenesis in the subdural space mimicking human-like features of progressively expanding hematoma.一种新型慢性硬脑膜下血肿大鼠模型:模拟血肿逐渐扩大的人类特征,在硬脑膜下腔诱导炎症和血管生成。
Brain Res Bull. 2021 Jul;172:108-119. doi: 10.1016/j.brainresbull.2021.04.024. Epub 2021 Apr 28.
5
Postoperative Subdural Air Collection Is a Risk Factor for Chronic Subdural Hematoma after Surgical Clipping of Cerebral Aneurysms.术后硬膜下积气是脑动脉瘤手术夹闭术后慢性硬膜下血肿的一个危险因素。
Neurol Med Chir (Tokyo). 2018 Jun 15;58(6):247-253. doi: 10.2176/nmc.oa.2018-0019. Epub 2018 May 11.
6
Correlation of vascular endothelial growth factor with magnetic resonance imaging in chronic subdural hematomas.慢性硬膜下血肿中血管内皮生长因子与磁共振成像的相关性
J Neurol Sci. 2017 Jun 15;377:149-154. doi: 10.1016/j.jns.2017.04.013. Epub 2017 Apr 12.
7
Nutritional and inflammatory peripheral blood markers for risk assessment of chronic subdural hematoma: a case-control study.营养和炎症外周血标志物对慢性硬脑膜下血肿风险评估的研究:病例对照研究。
Clin Neurol Neurosurg. 2023 Apr;227:107640. doi: 10.1016/j.clineuro.2023.107640. Epub 2023 Feb 25.
8
Extensive postoperative subdural fluid volume affects the onset of chronic subdural hematoma after unruptured aneurysmal clipping surgery.广泛的术后硬膜下液体积聚影响未破裂动脉瘤夹闭手术后慢性硬膜下血肿的发生。
Clin Neurol Neurosurg. 2019 Dec;187:105533. doi: 10.1016/j.clineuro.2019.105533. Epub 2019 Sep 28.
9
PlGF and sVEGFR-1 in chronic subdural hematoma: implications for hematoma development.胎盘生长因子和可溶性血管内皮生长因子受体-1 在慢性硬脑膜下血肿中的作用:对血肿形成的影响。
J Neurosurg. 2013 Feb;118(2):353-7. doi: 10.3171/2012.10.JNS12327. Epub 2012 Nov 9.
10
Cerebrospinal fluid leakage into the subdural space: possible influence on the pathogenesis and recurrence frequency of chronic subdural hematoma and subdural hygroma.脑脊液漏入硬膜下腔:对慢性硬膜下血肿和硬膜下积液的发病机制及复发频率的可能影响。
J Neurosurg. 2008 Feb;108(2):275-80. doi: 10.3171/JNS/2008/108/2/0275.

引用本文的文献

1
Gliomagenesis following chronic subdural hematoma: A case report.慢性硬膜下血肿后的胶质瘤发生:一例报告。
Exp Ther Med. 2025 May 16;30(1):139. doi: 10.3892/etm.2025.12889. eCollection 2025 Jul.
2
Cellular, Molecular and Clinical Aspects of Aortic Aneurysm-Vascular Physiology and Pathophysiology.主动脉瘤的细胞、分子和临床方面——血管生理学和病理生理学。
Cells. 2024 Feb 1;13(3):274. doi: 10.3390/cells13030274.
3
Efficacy of atorvastatin administration after surgery in patients with chronic subdural hematoma.阿托伐他汀在慢性硬脑膜下血肿术后的疗效。
Medicine (Baltimore). 2023 Sep 29;102(39):e35379. doi: 10.1097/MD.0000000000035379.
4
Subdural Lesions Linking Additional Intracranial Spaces and Chronic Subdural Hematomas: A Narrative Review with Mutual Correlation and Possible Mechanisms behind High Recurrence.连接额外颅内间隙与慢性硬膜下血肿的硬膜下病变:一项关于相互关联及高复发背后可能机制的叙述性综述
Diagnostics (Basel). 2023 Jan 8;13(2):235. doi: 10.3390/diagnostics13020235.
5
Angiogenetic Factors in Chronic Subdural Hematoma Development.慢性硬膜下血肿形成中的血管生成因子
Diagnostics (Basel). 2022 Nov 14;12(11):2787. doi: 10.3390/diagnostics12112787.
6
Immunoexpression of MMP-8 and MMP-9 in chronic subdural hematoma.基质金属蛋白酶-8和基质金属蛋白酶-9在慢性硬膜下血肿中的免疫表达
Front Neurol. 2022 Aug 17;13:988854. doi: 10.3389/fneur.2022.988854. eCollection 2022.

本文引用的文献

1
A novel rat model of chronic subdural hematoma: Induction of inflammation and angiogenesis in the subdural space mimicking human-like features of progressively expanding hematoma.一种新型慢性硬脑膜下血肿大鼠模型:模拟血肿逐渐扩大的人类特征,在硬脑膜下腔诱导炎症和血管生成。
Brain Res Bull. 2021 Jul;172:108-119. doi: 10.1016/j.brainresbull.2021.04.024. Epub 2021 Apr 28.
2
Significantly high concentrations of vascular endothelial growth factor in chronic subdural hematoma with trabecular formation.伴有小梁形成的慢性硬膜下血肿中血管内皮生长因子浓度显著升高。
Clin Neurol Neurosurg. 2021 Mar;202:106458. doi: 10.1016/j.clineuro.2020.106458. Epub 2021 Jan 6.
3
Multifunctional intracellular matrix metalloproteinases: implications in disease.多功能细胞内基质金属蛋白酶:疾病中的意义。
FEBS J. 2021 Dec;288(24):7162-7182. doi: 10.1111/febs.15701. Epub 2021 Jan 22.
4
Role of brain natriuretic peptide in the prediction of long-term surgical outcome of chronic subdural hematoma.脑钠肽在预测慢性硬膜下血肿长期手术结局中的作用。
J Neurol Sci. 2021 Jan 15;420:117240. doi: 10.1016/j.jns.2020.117240. Epub 2020 Nov 23.
5
Atorvastatin Combined with Low-Dose Dexamethasone Treatment Protects Endothelial Function Impaired by Chronic Subdural Hematoma via the Transcription Factor KLF-2.阿托伐他汀联合小剂量地塞米松治疗通过转录因子KLF-2保护慢性硬膜下血肿损伤的内皮功能。
Drug Des Devel Ther. 2020 Aug 12;14:3291-3299. doi: 10.2147/DDDT.S256050. eCollection 2020.
6
Updates in Chronic Subdural Hematoma: Epidemiology, Etiology, Pathogenesis, Treatment, and Outcome.慢性硬脑膜下血肿的最新研究进展:流行病学、病因学、发病机制、治疗和预后。
World Neurosurg. 2020 Sep;141:339-345. doi: 10.1016/j.wneu.2020.06.140. Epub 2020 Jun 25.
7
Analysis of Brain Natriuretic Peptide Serum Levels in Patients with Symptomatic Chronic Subdural Hematoma: A Potential Reliable Biomarker.症状性慢性硬脑膜下血肿患者脑利钠肽血清水平分析:一种潜在可靠的生物标志物。
J Neurotrauma. 2020 Oct 15;37(20):2211-2218. doi: 10.1089/neu.2020.7110. Epub 2020 Jun 25.
8
Assessment of peripheral blood cell inflammatory markers in patients with chronic subdural hematoma.评估慢性硬脑膜下血肿患者外周血炎性标志物。
Clin Neurol Neurosurg. 2020 Apr;191:105738. doi: 10.1016/j.clineuro.2020.105738. Epub 2020 Feb 17.
9
Treatment of chronic subdural hematoma with atorvastatin combined with low-dose dexamethasone: phase II randomized proof-of-concept clinical trial.阿托伐他汀联合小剂量地塞米松治疗慢性硬膜下血肿:II期随机概念验证临床试验
J Neurosurg. 2020 Jan 31;134(1):235-243. doi: 10.3171/2019.11.JNS192020. Print 2021 Jan 1.
10
Drug treatment of chronic subdural hematoma.慢性硬脑膜下血肿的药物治疗。
Expert Opin Pharmacother. 2020 Mar;21(4):435-444. doi: 10.1080/14656566.2020.1713095. Epub 2020 Jan 20.

血清中基质金属蛋白酶-8和基质金属蛋白酶-9水平作为慢性硬膜下血肿的标志物

Serum Levels of MMP-8 and MMP-9 as Markers in Chronic Subdural Hematoma.

作者信息

Su Gao-Jian, Gao Jie, Wu Chu-Wei, Zou Jun-Feng, Zhang Di, Zhu Dong-Liang, Liu Jun, Zhang Jie-Hua, Huang Xian-Jian

机构信息

Shenzhen Key Laboratory of Neurosurgery, Department of Neurosurgery, the First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen 518000, China.

出版信息

J Clin Med. 2022 Feb 9;11(4):902. doi: 10.3390/jcm11040902.

DOI:10.3390/jcm11040902
PMID:35207175
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8878690/
Abstract

Chronic subdural hematoma (CSDH) is a common neurological disease that involves the collection of blood products in the subdural space. The progression of CSDH is an angiogenic and inflammatory process, but the multifactorial mechanisms underlying CSDH are still not fully understood. We aimed to identify one or more factors that may play an important role in the development of CSDH. We enrolled 83 patients with CSDH, including 17 postoperative patients, and analyzed 20 markers in the hematoma fluid and peripheral blood of each patient. Overall differential gene expression was examined to identify the representative markers. The concentration of MMP-8 was significantly lower in the postoperative group than in the preoperative group. The concentration of MMP-9 was significantly higher in the postoperative group than in the preoperative group. These findings indicate that MMP-8 and MMP-9 may play important roles in the pathophysiology of CSDH. Understanding the pathways associated with CSDH may provide insights for improving disease outcomes.

摘要

慢性硬膜下血肿(CSDH)是一种常见的神经系统疾病,涉及硬膜下间隙血液产物的积聚。CSDH的进展是一个血管生成和炎症过程,但CSDH潜在的多因素机制仍未完全了解。我们旨在确定一个或多个可能在CSDH发展中起重要作用的因素。我们纳入了83例CSDH患者,包括17例术后患者,并分析了每位患者血肿液和外周血中的20种标志物。通过检查总体差异基因表达来确定代表性标志物。术后组MMP-8浓度显著低于术前组。术后组MMP-9浓度显著高于术前组。这些发现表明MMP-8和MMP-9可能在CSDH的病理生理学中起重要作用。了解与CSDH相关的途径可能为改善疾病预后提供思路。